European Journal of Preventive Cardiology

Article	Citations
COP27 Climate Change Conference: urgent action needed for Africa and the world	531
Integrating lipoprotein(a) into preventive cardiology: probably important to get the measurement right	298
Anabolic steroids in athletes: the interplay of hormones and inflammation leading to the heart’s vulnerability	254
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from	206
Cardiorespiratory fitness in relation to systolic and diastolic function in patients with heart failure and chronic coronary syndromes	184
Sex specific association of body composition with sphingosine-1-phosphate levels-results from the study of health in pomerania (SHIP) analysis	123
Characteristics and risk of coronary-related events following hospitalisation for chronic coronary disease	119
Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia	108
Exercise doppler Echocardiography of the right heart and pulmonary circulation in patients with cardiovascular risk factors: observations from the RIGHT Heart International NETwork (RIGHT-NET)	97
Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population	93
Statin therapy eligibility in a large primary prevention cohort according to European Society of Cardiology Guidelines	89
Sports-related sudden cardiac arrest: a video analysis of characteristics and outcomes	82
The role of the arrhythmologist in a sports cardiology centre: the devil is in the detail	80
Secondary prevention of Coronary Heart Disease (CHD) in the Moroccan population. Survey of Risk Factor (SURF) CHD II Morocco	79
Enhancement of left ventricular compliance in twin pregnancy	77
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study	76
Effects of a behavioral psychological intervention in addition to an exercise rehabilitation program in chronic heart failure patients	72
Carotid intima-media thickness progression and plaque formation in recreational male endurance athletes - a 10-year follow-up study	72
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study	69
Effect of preventive training in cardiac transcriptoma in rats with pulmonary hypertension	67
Effect of hybrid cardiac rehabilitation using a smart device: a randomized controlled trial	66
Social networks as a predictor of cardiovascular disease incidence and mortality: 10-year observation of the Polish HAPIEE cohort	65
Exercise cardiac magnetic resonance imaging in heart failure with preserved ejection fraction	65
Modelling the long-term clinical outcomes of AI-enabled CCTA plaque quantification on preventive cardiovascular management	63
Differences in 10-year cardiovascular risk estimation using SCORE and SCORE2 risk prediction tools: a moderate risk country population analysis	62

Cardiovascular rehabilitation - determinants of long-term outcomes	62
Supraventricular tachycardia (SVT) and high troponin levels: patient characteristics and evaluation of coexisting coronary artery disease	59
Impact of type D personality on clinical outcomes in Spanish patients with myocardial infarction	57
Safety and efficacy of antiplatelet cessation after transcatheter patent foramen ovale closure	54
Women-focused cardiac rehabilitation delivery around the world and program enablers to support broader implementation	50
Prolonged troponin elevation after high-intensity exercise may indicate coronary artery disease	49
Effect of dapagliflozin on pro-oxidant/antioxidant balance and renal function in patients with diabetic kidney disease to reduce the risk of cardiovascular events	49
Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization	48
Clinical and instrumental follow-up and return to sport after surgical correction of anomalous origin of coronary arteries in young athletes	47
Prognostic significance of non-ischemic computational pressure-flow dynamics derived fractional flow reserve in stable coronary artery disease patients in LAD versus non-LAD artery lesions	47
Education training on physical activity in italian medical university courses: a call for action	46
LDL-C target attainment in the secondary prevention of atherosclerotic cardiovascular disease in Albania: barriers and strategies to reach the goals	46
The importance of an individualized approach to risk assessment in Fontan patients considering pregnancy	46
Cardiovascular risk assessment in male and female patients with and without depression: an electronic health record evaluation in Wales	45
RETRACTED AND REPLACED: Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease	45
Respiratory vaccines as cardiovascular prevention: evidence from four landmark trials	44
Prevalence of ventricular arrhythmias in apparently healthy workers: results from Ferrari Formula Benessere	43
Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy	43
Inconsistent association between lipoprotein(a) and coronary artery calcium	42
Visceral adiposity, aortic stiffness, and cardiovascular risk	42
Effects of inspiratory muscle training on NT-proBNP level, functional exercises capacity and quality of life in patients with cardiac resynchronization therapy: a pilot study	41
Nocturnal hypoxaemic burden is associated with incident major adverse cardiovascular events in patients with type 2 diabetes	41
Effect of acetaminophen on blood pressure: a systematic review and meta-analysis of randomized controlled trials	41
Preventing atherosclerosis: rethinking the starting line	40
Human intravenous immunoglobulins for recurrent pericarditis: a multicentre cohort study	40
The role of inflammation in longitudinal renal function decline and incident chronic kidney disease: the multi-ethnic study of atherosclerosis	40
Variations in blood pressure after a 75 g oral glucose load and their implications for detecting hypertension and postprandial hypotension in Chinese adults: a cross-sectional study	40
Impact of neighbourhood socio-economic status on cardiovascular risk factors in a French urban population	39
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry	39
Flexible addition of risk modifiers on top of SCORE2 to improve long-term risk prediction in healthy individuals	39
Improvements in walking speed reduce mortality in patients with cardiovascular disease during exercise-based secondary prevention: findings from the ITER registry	38
A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels	38
Prime time for (im) precision medicine: from randomized clinical trials to real-world evidence	38
PO09 Advanced genomic exploration to identify and propose microRNAs involved in Cardiac arrhythmia as potential therapeutic targets	37
The ‘environmental exposome’ as a target to reimagine the cardiovascular prevention	37
PO51 Restrictive cardiomyopathy and sudden cardiac arrest in a young female: Case report of a TNNI3 variant	36
PO88 Mavacamten in Noonan syndrome: clinical benefits mediated by an off-target mechanism	36
Comparison of radial artery occlusion occurrence (RAO) between compression band device and manually applied gauze compression after transradial coronary procedure, a PROBE study	35
Correction to: Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: the TRAINING-HR randomized clinical trial	35
Gender differences in cardiovascular events among patients with sleep apnoea syndrome: a real-world data analysis of a nationwide epidemiological dataset	34
Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes	34
‘Genetic modelling of triglyceride-rich lipoprotein/remnant lowering mimics APOC3-silencing and predicts clinically relevant coronary heart disease event reductions’: author’s response	34
Increased cancer incidence in patients with pre-existing heart failure: results from a French nationwide cohort study	34
Why Type D personality matters for cardiovascular health after acute coronary syndrome	33
Association of cardiovascular-kidney-metabolic overlap with physical function and prognosis in older patients with heart failure: a post hoc analysis of the FRAGILE-HF and SONIC-HF	33
Cardiovascular health is the essential but overlooked aspect in the management of cancer survivors	33
Effect of semaglutide on mortality and cardiovascular events in patients at high cardiovascular risk: an updated systematic review and meta-analysis	33
A comprehensive analysis of the impact of high-intensity interval vs. moderate-intensity continuous training on global and regional myocardial function in patients early after acute myocardial infarct	33
Burden of cardiometabolic disorders and lifetime risk of new-onset atrial fibrillation among men and women: the Rotterdam Study	33
Early adulthood exercise capacity, but not muscle strength, associates with subclinical atherosclerosis 40 years later in Swedish men	33

Prognostic value of CT-derived epicardial adipose tissue volume over coronary artery calcium in systemic lupus erythematosus	33
Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study	32
Baroreflex: ready for prime-time?	32
The role of sleep and sleep disorders in the new 2024 European Society of Cardiology guidelines	32
Inflammation as a missing dimension in early risk stratification after myocardial infarction	32
Impact of cumulative LDL cholesterol and other risk factors on coronary artery disease prevalence in patients with familial hypercholesterolaemia	32
Preventing the stiffening aorta: a call for sex-specific hypertension management in midlife	32
ASCVD risk stratification using apolipoprotein B and the LDL-C to total cholesterol ratio	31
Association of apolipoprotein levels with all-cause and cardiovascular mortality	31
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice	31
Diagnosing chronotropic incompetence: a scoping review of current approaches and their application in a cardiac rehabilitation cohort	31
Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents	31
Normal echocardiographic and electrocardiographic indices in young female athletes: a meta-analysis across sex, types of sports, races, and ethnicities	30
A note on base rates and applicability of screeners of psychological disorder in adults with congenital heart disease	30
The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank	30
Bone mineral loss and risk of atrial fibrillation: a multicohort study	30
Assessment of heart rate and oxygen consumption during and following a six-minute walk test in patients awaiting liver transplant	29
Prognostic value of BMI, NRS2002, and age in predicting in-hospital mortality for acute myocardial infarction: insights from a retrospective analysis	29
Life essential 8 associated with a lower risk of stroke: ideal cardiovascular health in the EPIC-NL prospective cohort study	29
Analysis of the diagnostic value of pre-arrhythmia electrogram storage function of cardiac electronic implantable devices for the diagnosis of cardiac arrhythmias	29
Exercise-based cardiac rehabilitation for patients with atrial fibrillation receiving catheter ablation: associations with long-term clinical outcomes	29
Efficacy and safety of direct oral anticoagulants versus warfarin in obese patients: a systematic review and meta-analysis of 31 studies	29
Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study	29
Endurance training protects the heart during maximal exercise in long-distance runners	28
Psychosocial outcomes after a home cardiac rehabilitation program	28
Balancing methodological rigour and clinical relevance in lipid variability research	28
Association of 10-year blood pressure trajectory with calcification volume in different vessel beds	28
Lipoprotein(a) and referrals to a specialist lipid clinic	28
Exercise and phenotypic progression in arrhythmogenic cardiomyopathy	28
Chronotropic index, heart rate and exercise capacity in diabetes mellitus: comparing two different high-intensity interval training protocols	28
Estimating cardiorespiratory fitness in heart failure patients with self-reported questionnaires	28
Cardio-oncological telerehabilitation during and after chemotherapy in breast cancer patients: impact on exercise capacity and quality of life	28
Diagnosis first: assessing kidney function in cardiovascular rehabilitation patients	28
Impact of cardiac rehabilitation on functional capacity and body composition across the heart failure spectrum	27
Characteristics of women attending a phase 3 cardiovascular rehabilitation program: is there a need for a more tailored intervention?	27
Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis	27
Association of right and left atrial strain with laboratory, anthropometric and echocardiographic markers - the influence of COVID-19 pandemic	27
Do triglycerides impact cardiovascular outcomes? A 10-year follow up study from a Portuguese cohort	27
Chemosensitivity and its association with exercise ventilation inefficiency in patients with chronic coronary syndromes compared to heart failure	27
Physical activity and autonomic function in patients with heart failure: a mediation analysis of functional exercise capacity	27
When the smoke clears: the enduring threat of tobacco in stable coronary artery disease	26
STELA (systematic technology for enhanced longevity and atherosclerosis prevention): development and initial implementation of a novel platform for population-based primary cardiovascular prevention	26
Association between changes in 6-minute walk distance and usual gait speed and prognosis in patients aged 75 years or older with cardiovascular disease	26
The influence of triglyceride and low-density-lipoprotein target levels on microcirculation	26
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	26
Socioeconomic status and recurrent cardiovascular events: preventing the worst or striving for the best?	26
Intensive blood pressure lowering and the risk of new-onset diabetes in patients with hypertension: a post-hoc analysis of the STEP randomized trial	26
Lipid-lowering therapy for cardiovascular risk management in the older patients: How far should we go?	26
Association and predictive value of immunoglobulin and complement levels for incident coronary heart disease: a nested case-control study in Chinese adults	26
High lipoprotein(a)—a lifelong risk factor and mortality predictor	26
Coronary artery calcium score in the young: is it time to update the guidelines?	25
Life’s essential 8 and progression of cardiometabolic multimorbidity trajectory: a prospective study of UK biobank	25
Is our destiny written in our genes? A sentence or an opportunity to prevent cardiovascular diseases?	25
Influenza vaccination: a call for cardiologists	25
Exercise training and regression of coronary atheromatous plaques	25
Editorial comments: Focus on cardiovascular risk screening	25
Unveiling the gender divide in heart failure prognosis: new insights from a comprehensive meta-analysis	25
Exercise oscillatory breathing in heart failure with reduced ejection fraction: clinical implication	25
To prevent hypertension in Africans: do we need to eat more vegetables?	25
Comment on ‘Anabolic–androgenic steroids and cardiac function’	24
Is it time to get SIRIUS aboutin silicomodelling of cardiovascular outcomes trials?	24
Editorial comments: focus on cardiovascular risk in type 2 diabetes mellitus and metabolic disorders	24
A forward-looking approach in women living with the Fontan circulation: from cardio-obstetric to cardio-reproductive medicine	24
Sex-specific time trends in incident atrial fibrillation and the contribution of risk factors: the Tromsø Study 1994–2016	23
Mobile health interventions in preventive cardiology: contrasting implementation between Europe and Asia	23
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors	23
Validity and reproducibility of the two-minute step test in older patients undergoing transcatheter aortic valve implantation	23
Association between high occupational physical workload and ischaemic heart disease, and the influence of cardiorespiratory fitness in 284 436 Swedish men	22
From narrowing to vulnerability: rethinking carotid revascularization in the era of advanced imaging	22
Association of genetically predicted problem alcohol use with risk of atrial fibrillation: a Mendelian randomization study	22
High blood pressure puts a high pressure in low- and middle-income countries	22
Life’s Essential 8 and the risk of cardiovascular disease death and all-cause mortality in Finnish men	22
High-risk coronary atherosclerosis at coronary computed tomography angiography in patients with Family histoRy of coronary Artery disease: an InTERnational multicentre study (The FRATER Study)	22
Hypnotic use and the risk of cardiovascular diseases in insomnia patients	22
Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction	22
The positive impact of the Life's Essential 8 in the prevention of incident heart failure	21
Echocardiographic findings in COVID: incidence of carditis and correlations with COVID variants	21
From heavy smog to healthy hearts: China’s clean air act as a blueprint for cardiovascular disease prevention	21
Cardiovascular disease and mental health: a dangerous duo?	21
Atrial fibrillation in female endurance athletes	21

Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study	21
Comment on ‘Severe obesity in patients with ST-elevation myocardial infarctions: association with age, temporal trends, and clinical outcomes’	20
Meditation as a stress management strategy in cardiac rehabilitation for coronary artery disease patients: a randomized controlled trial	20
The impact of cardiac SPECT in risk stratification for women with suspected coronary artery disease in a very high cardiovascular risk country	20
Lipoprotein(a) and new-onset atrial fibrillation: where does the evidence lead us?	20
Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?: Reply	20
Arrhythmic prevalence during Harvard Step Test and Maximal Exercise Test in young athletes: a comparative analysis	20
Association of nt-probnp and left ventricular ejection fraction and their utility as predictors of in-hospital mortality among heart failure patients admitted in a tertiary hospital in davao city	20
Identifying lifestyle patterns and awareness of cardiovascular disease among women in lombardy-italy: insights from the a call for women project	20
Hyper-trabeculation in olympic athletes: advanced LV function analysis by CMR	20
Usefulness of impedanciometry for the assessment of obesity in a high risk dyslipidemia screening unit	20
Severe dyslipidemia title: known by patients, but is it treated?	20
Critical review of the studies identifying determinants of a change in fitness following a cardiac rehabilitation outpatient programme	20
Exercise hemodynamics and metabolisms in (very) sportive patients after orthotopic heart transplantation	20
Can we prevent cardiac conduction disease?	20
Improved adherence to guideline-recommended treatments in a specialist preventative pharmacology clinic compared to standard cardiology clinics after an acute coronary syndrome	20
Association of endogenous oxidants and antioxidants with risk of atherosclerotic cardiovascular disease	20
Acute myocardial infarction triggered by physical exertion: a systematic review and meta-analysis	19
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database	19
Efficacy and safety of aspirin for primary prevention in adults with elevated lipoprotein(a) or genetic susceptibility via LPA gene variants: a systemati	19
Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease	19
Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden	19
Ahead of kick-off: sports cardiology in focus	19
Overview of Cardiac Rehabilitation following post-acute myocardial infarction in European Society of Cardiology member countries	19
PO100 Genetic analysis and electrocardiographic patterns in Brugada syndrome: a comprehensive multi-tiered approach	19
Associations of plant-based diets with all-cause and cause-specific mortality and life expectancy among participants with cardiometabolic disorders from UK, USA, and China	19
Ischaemic stroke polygenic risk score and recurrent cardiac and cerebrovascular events after coronary artery revascularization	19
Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre	19
Making a quality diagnosis of familial hypercholesterolaemia in children	18
PO20 Multi-trait polygenic risk scores improve genomic prediction of atrial fibrillation across diverse ancestries	18
Extension of heterozygous familial hypercholesterolaemia treatment recommendations by including both low-density lipoprotein and lipoprotein(a) burden: a unique opportunity to improve patient prognosi	18
The adding value of non-invasive assessment of stroke volume during cardiopulmonary exercise testing in hypertrophic cardiomyopathy: beyond O2-pulse	18
Aspirin and lipoprotein(a): lessons from replication at scale	18
Genetically predicted adipose tissue distribution influences the risk of atherosclerosis	18
Accelerometer-measured circadian alignment predicts all-cause and cardiovascular mortality in middle-aged and older adults	18
Lipid management after an acute coronary syndrome: reasons to hope, reasons to persist	18
Comprehensive cardiac rehabilitation in elderly patients with heart failure: age is just a number?	18
Genetic risk disclosure and behavioural change: not so fast	18
Exercise intensity and cardiac disease development in carriers of titin variants	18
Left atrial dysfunction predicts left ventricular remodelling in patients with preserved ejection fraction after acute ST-elevation myocardial infarction	18
Smoking timing, genetic susceptibility, and the risk of incident atrial fibrillation: a large prospective cohort study	18
Navigating omega-3s	18
Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study	18
Cardiology’s blind spot: mental health	18
Increased nation-wide uptake after establishment of comprehensive outpatient cardiac centres in Slovenia: an interrupted time-series	17
Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry	17
Frailty as a risk-enhancing factor across the cardiovascular–kidney–metabolic framework: findings from the UK Biobank	17
Obesity and cardiovascular health	17
The impact of BMI into the ESC SCORE2 model on cardiovascular risk reclassification: results from a 20-year cohort study	17
Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE	17
Cardiac Troponins and SARS-CoV-2: Subclinical Myocardial Injury as he Long Shadow of the Pandemic	17
Exposure to ultra-processed food and risk of cardiovascular mortality: a prospective cohort study	17
Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study	17
Physical functioning predicts cognition in systolic heart failure	17
Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank	17
Effects of endurance exercise training on left ventricular structure in healthy adults: a systematic review and meta-analysis	17
The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis	17
Anticoagulation of post-operative atrial fibrillation during cardiac rehabilitation	16
Decline of physical performance in patients with transthyretin amyloid cardiomyopathy assessed by cardiopulmonary exercise testing	16
Cardiovascular pathologies in post-covid syndrome	16
Associations of anthropometric markers with arterio-venous ratio in the general population	16
Apolipoprotein B and cardiovascular risk in asymptomatic patients: need for systematic evaluation?	16
Increased cardiometabolic index is associated with impaired exercise capacity and heart failure with preserved ejection fraction in old hypertensives	16
Cardiac rehabilitation can change the destiny of the patient with ST-elevation acute coronary syndrome	16
Different isometric exercise modalities induce divergent acute effects on myocardial work efficiency in hypertensive patients with coronary heart disease	16
Statin therapy in chronic heart failure with reduced ejection fraction: a post-hoc analysis of T.O.S.C.A. Registry	16
Environmental noise exposure and prognosis after an acute myocardial infarction: findings from ENVI-MI study	16
Changes in physical activity levels following different exercise modalities in patients with atrial fibrillation: a 1-year follow-up	16
Predictive value of HCO3- on the no-reflow phenomenon in STEMI patients	16
Chronic adaptations to exercise in thin-walled chambers of the heart: a longitudinal study echocardiographic study of elite athletes	16
Tailored interventions to improve adherence to antihypertensive treatment and reduce blood pressure: findings from a systematic review and meta-analysis	16
Impact of phase ii exercise-based cardiac rehabilitation on HDL-c levels and the predictive role of systemic inflammatory index in patients with coronary artery disease	15
Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy	15
Editorial ‘Outpatient cardiac rehabilitation in patients with heart failure: real world news’	15
Inequalities in the provision of guideline-directed medical therapy following myocardial infarction	15
Different patterns of lifestyles, sociodemography, clinical patterns, and cardiovascular health awareness among women: results from the ‘Call for Women’ population-based survey	15
Lipoprotein(a), are its levels really invariable?	15
Hemoglobin, maximal heart rate and work capacity, as well as time to exhaustion are significantly improved with combined hypoxia and aerobic exercise training in healthy adults: a meta-analysis	15
Shared genetic associations and aetiology between obstructive sleep apnoea and cardiovascular diseases: a genome-wide cross-trait analysis and bidirectional Mendelian randomization analysis	15
High-intensive interval training for inducing coronary plaque regression: is it the best choice?	15
Longitudinal insights into coronary plaque amongst master athletes	15
Doctor-patient communication about personal cardiovascular risk: a missing piece of the prevention puzzle?	15
Sudden cardiac arrest and role of sport preparticipation screening in children	15
Insomnia in patients with myocardial infarction with and without obstructive coronary arteries: prevalence and prognosis	15
Aortic valve sclerosis and subclinical left ventricular dysfunction in the general population with normal left ventricular geometry	15
Do low levels of albuminuria predict mortality among young adults without major cardiovascular risk factors?	15
Analysis of an acute effect of air pollution on cardiovascular mortality in Eastern Poland (EP-PARTICLES study)	15
SGLT2i effects depending on functional capacity in ATTR-CM	15
Adding parenteral anticoagulation in STEMI undergoing PCI: safety and efficacy?	15
Cardiovascular risk in multiple sclerosis: exploring the role of vitamin D - insights from the Cardio-MS project	15
Characterization of ventilatory efficiency during cardiopulmonary exercise testing in healthy athletes	14
Interpreting conditional completion in ethnic inequalities in cardiac rehabilitation	14
Intervention is needed in polycystic ovary syndrome for prevention of cardiovascular diseases	14
Development of deep-learning models for real-time anaerobic threshold and peak VO2 prediction during cardiopulmonary exercise testing	14
Cardiovascular prevention at the crossroads	14